Phase 3 Clinical Trial for Systemic Scleroderma Resumes Recruiting Patients
According to a story from PR Newswire, the drug company CiVi Biopharma, Inc. today announced that its subsidiary Eicos Sciences, Inc. has resumed recruiting patients for its phase 3 clinical…